IL6 and metabolic dysfunction-associated steatotic liver disease: In MASLD, hepatocyte injury and lipotoxicity trigger immune responses that increase the levels of pro-inflammatory factors (7), such as interleukin (IL)-6 and CC-chemokine ligand 2 (CCL2), contributing to chronic inflammation and stimulation of the sympathetic nervous system (SNS), which can increase BP.